Yuriditsky E, Torres J, Izmirly P M, Belmont H M
New York University School of Medicine, New York, USA.
Lupus. 2018 Dec;27(14):2269-2273. doi: 10.1177/0961203318804876. Epub 2018 Oct 5.
Non-bacterial thrombotic endocarditis in antiphospholipid syndrome presents a management dilemma. Large mobile valvular lesions pose an increased risk of stroke and arterial embolization. However, surgical excision or valve replacement in such patients carries high morbidity and mortality, while anticoagulation alone has limited data. We describe two patients with antiphospholipid syndrome presenting with neurologic events and large non-bacterial aortic valve vegetations. Both patients were successfully managed with anticoagulation and demonstrated rapid dissolution of lesions without evidence of recurrent embolic events. We provide a literature review describing additional cases managed with anticoagulation with dissolution of valvular lesions over time. Our cases further support the efficacy and safety of anticoagulation in patients with antiphospholipid syndrome and non-bacterial thrombotic endocarditis in the context of arterial embolization.
抗磷脂综合征中的非细菌性血栓性心内膜炎带来了治疗难题。大型可移动瓣膜病变会增加中风和动脉栓塞的风险。然而,此类患者进行手术切除或瓣膜置换的发病率和死亡率很高,而单纯抗凝治疗的数据有限。我们描述了两名患有抗磷脂综合征并出现神经系统事件和大型非细菌性主动脉瓣赘生物的患者。两名患者均通过抗凝治疗成功治愈,赘生物迅速溶解,且无复发性栓塞事件的迹象。我们进行了文献综述,描述了其他通过抗凝治疗使瓣膜赘生物随时间溶解的病例。我们的病例进一步支持了在动脉栓塞情况下,抗凝治疗对于抗磷脂综合征和非细菌性血栓性心内膜炎患者的有效性和安全性。